METHOD OF DETERMINING CANCER PROGNOSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14682545

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a method of predicting the prognosis of a patient with ovarian cancer by determining the total number of somatic exome mutations per genome (Nmut) and status of the BRCA1 and/or BRCA2 in the subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DANA-FARBER CANCER INSTITUTE INC450 BROOKLINE AVENUE BOSTON MA 02215

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Birbak, Nicolai Juul Copenhagen, DK 1 8
Iglehart, James Dirk Boston, US 2 8
Matulonis, Ursula Lexington, US 1 8
Richardson, Andrea L Chestnut Hill, US 6 46
Szallasi, Zoltan Boston, US 14 91
Wang, Zhigang C Newton, US 5 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation